Article
Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells
2025-12-14
Abstract excerpt
<h4>ABSTRACT</h4> Primary human myeloid cells are promising candidates for immunotherapy, yet efficient and scalable technologies for genetic engineering and screening in these cells are limited. Here we present a virus-like particle (VLP)-based toolkit that delivers diverse CRISPR genome editing modalities to human monocytes, macrophages, and dendritic cells with high efficiency while preserving viability and in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0c7910b5-c9e7-517b-aa09-b63a692445f8
- DOI
- 10.64898/2025.12.14.692434
